share_log

Bruush Oral Care | 6-K: Report of foreign private issuer (related to financial reporting)

Bruush Oral Care | 6-K: Report of foreign private issuer (related to financial reporting)

Bruush Oral Care | 6-K：外国发行人报告（业绩相关）
美股SEC公告 ·  01/05 00:00
Moomoo AI 已提取核心信息
Bruush Oral Care Inc. completed two significant financing transactions in January 2024. The company closed a private placement on January 1, 2024, with Generating Alpha Ltd., raising $500,000 through the issuance of a pre-funded common share purchase warrant exercisable for 16,500,000 common shares at $0.001 each. Additionally, Bruush Oral Care agreed to file a registration statement for these shares within 45 days post-closing. On the same day, the company also entered into a convertible note financing agreement with Generating Alpha Ltd. for up to $6 million, with an initial funding of $1.5 million received on January 5, 2024. The note, maturing in one year with an interest rate of 12% or WSJ Prime Rate plus 3.5%, is convertible into common shares at a price of $0.1625 per share or 80% of the lowest...Show More
Bruush Oral Care Inc. completed two significant financing transactions in January 2024. The company closed a private placement on January 1, 2024, with Generating Alpha Ltd., raising $500,000 through the issuance of a pre-funded common share purchase warrant exercisable for 16,500,000 common shares at $0.001 each. Additionally, Bruush Oral Care agreed to file a registration statement for these shares within 45 days post-closing. On the same day, the company also entered into a convertible note financing agreement with Generating Alpha Ltd. for up to $6 million, with an initial funding of $1.5 million received on January 5, 2024. The note, maturing in one year with an interest rate of 12% or WSJ Prime Rate plus 3.5%, is convertible into common shares at a price of $0.1625 per share or 80% of the lowest volume-weighted average price of the ten trading days prior to conversion. The note includes full ratchet anti-dilution protections and additional terms in the event of default. EF Hutton LLC served as the placement agent for the financing. The company is required to file an initial registration statement for the convertible note within 30 days following January 1, 2024.
Bruush Oral Care Inc.在2024年1月完成了两项重要的融资交易。该公司于2024年1月1日与Generating Alpha Ltd.完成了一项定向增发交易，发行面值为每股0.001美元的预融资普通股购买权，可行使购买1650万股普通股，募集500,000美元。此外，Bruush Oral Care还同Generating Alpha Ltd.签署了一份转换票据融资协议，最高融资额为6百万美元，于2024年1月5日获得了150万美元的首笔融资。票据期限为一年，利率为12%或WSJ Prime Rate加3.5%，可转换为每股0.1625美元的普通股或转换前10个交易日的最低成交量加权平均价的80%。票据包括全面的防稀释条款和违约情况下的附加条款。EF Hutton LLC担任融资的包销商。公司必须在2024年1月1日后30天内提交可转换票据的初始注册声明。
Bruush Oral Care Inc.在2024年1月完成了两项重要的融资交易。该公司于2024年1月1日与Generating Alpha Ltd.完成了一项定向增发交易，发行面值为每股0.001美元的预融资普通股购买权，可行使购买1650万股普通股，募集500,000美元。此外，Bruush Oral Care还同Generating Alpha Ltd.签署了一份转换票据融资协议，最高融资额为6百万美元，于2024年1月5日获得了150万美元的首笔融资。票据期限为一年，利率为12%或WSJ Prime Rate加3.5%，可转换为每股0.1625美元的普通股或转换前10个交易日的最低成交量加权平均价的80%。票据包括全面的防稀释条款和违约情况下的附加条款。EF Hutton LLC担任融资的包销商。公司必须在2024年1月1日后30天内提交可转换票据的初始注册声明。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

独立文件7  查看翻译

独立文件8  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息